A detailed history of Baystate Wealth Management LLC transactions in Ikena Oncology, Inc. stock. As of the latest transaction made, Baystate Wealth Management LLC holds 2,999 shares of IKNA stock, worth $5,158. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,999
Previous 2,999 -0.0%
Holding current value
$5,158
Previous $12,000 58.33%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Sep 21, 2023

BUY
$3.5 - $7.31 $10,496 - $21,922
2,999 New
2,999 $19,000
Q4 2021

Jan 21, 2022

BUY
$10.52 - $16.96 $31,549 - $50,863
2,999 New
2,999 $38,000

Others Institutions Holding IKNA

About Ikena Oncology, Inc.


  • Ticker IKNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,257,500
  • Market Cap $62.4M
  • Description
  • Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...
More about IKNA
Track This Portfolio

Track Baystate Wealth Management LLC Portfolio

Follow Baystate Wealth Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baystate Wealth Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baystate Wealth Management LLC with notifications on news.